Clinical Trial Update: Cardiovascular Vulnerability to Particulate Exposure

View source ↗

Summary

The NIEHS-sponsored clinical trial investigating cardiovascular vulnerability to particulate exposure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Lung Disease

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Heart Disease, Lung Disease | Status: COMPLETED